Global Sciatica Treatment Market 2023-2027

Description

List of Tables

The sciatica treatment market is forecasted to grow by USD 3089.08 mn during 2022-2027, accelerating at a CAGR of 4.83% during the forecast period. The report on the sciatica treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising awareness about sciatica, growing prevalence of risk factors for sciatica, and regulatory support for pipeline drugs.

Technavio's sciatica treatment market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	4.13%
CAGR	4.83%
Incremental Value	$3,089.08mn

By End-user

Hospital
Clinics
Others

By Product

Non-surgical treatment
Surgical treatment

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of clonidine micropellet epidural injections as one of the prime reasons driving the sciatica treatment market growth during the next few years. Also, increasing funds for research on sciatica and rising awareness of physiotherapy for sciatica treatment will lead to sizable demand in the market.

The report on the sciatica treatment market covers the following areas:

Sciatica treatment market sizing
Sciatica treatment market forecast
Sciatica treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sciatica treatment market vendors that include Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr Reddys Laboratories Ltd., Elam Pharma Pvt. Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, KOLON LIFE SCIENCE, Lupin Ltd., Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the sciatica treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73640

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global Sciatica Treatment Market 2023-2027 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospital - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
6.4 Clinics - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 48: Chart on Product - Market share 2022-2027 (%)
Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Non-surgical treatment - Market size and forecast 2022-2027
Exhibit 52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
7.4 Surgical treatment - Market size and forecast 2022-2027
Exhibit 56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Apotex Inc.
Exhibit 111: Apotex Inc. - Overview
Exhibit 112: Apotex Inc. - Product / Service
Exhibit 113: Apotex Inc. - Key offerings
12.4 Aurobindo Pharma Ltd.
Exhibit 114: Aurobindo Pharma Ltd. - Overview
Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
12.5 Bayer AG
Exhibit 117: Bayer AG - Overview
Exhibit 118: Bayer AG - Business segments
Exhibit 119: Bayer AG - Key news
Exhibit 120: Bayer AG - Key offerings
Exhibit 121: Bayer AG - Segment focus
12.6 Dr Reddys Laboratories Ltd.
Exhibit 122: Dr Reddys Laboratories Ltd. - Overview
Exhibit 123: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 124: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 125: Dr Reddys Laboratories Ltd. - Segment focus
12.7 Elam Pharma Pvt. Ltd.
Exhibit 126: Elam Pharma Pvt. Ltd. - Overview
Exhibit 127: Elam Pharma Pvt. Ltd. - Product / Service
Exhibit 128: Elam Pharma Pvt. Ltd. - Key offerings
12.8 Fresenius SE and Co. KGaA
Exhibit 129: Fresenius SE and Co. KGaA - Overview
Exhibit 130: Fresenius SE and Co. KGaA - Business segments
Exhibit 131: Fresenius SE and Co. KGaA - Key news
Exhibit 132: Fresenius SE and Co. KGaA - Key offerings
Exhibit 133: Fresenius SE and Co. KGaA - Segment focus
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 Hikma Pharmaceuticals Plc
Exhibit 137: Hikma Pharmaceuticals Plc - Overview
Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
12.11 Johnson and Johnson
Exhibit 141: Johnson and Johnson - Overview
Exhibit 142: Johnson and Johnson - Business segments
Exhibit 143: Johnson and Johnson - Key news
Exhibit 144: Johnson and Johnson - Key offerings
Exhibit 145: Johnson and Johnson - Segment focus
12.12 Novartis AG
Exhibit 146: Novartis AG - Overview
Exhibit 147: Novartis AG - Business segments
Exhibit 148: Novartis AG - Key offerings
Exhibit 149: Novartis AG - Segment focus
12.13 Omega Laser Systems Ltd.
Exhibit 150: Omega Laser Systems Ltd. - Overview
Exhibit 151: Omega Laser Systems Ltd. - Product / Service
Exhibit 152: Omega Laser Systems Ltd. - Key offerings
12.14 Ozone Pharmaceuticals Ltd.
Exhibit 153: Ozone Pharmaceuticals Ltd. - Overview
Exhibit 154: Ozone Pharmaceuticals Ltd. - Key offerings
12.15 Pfizer Inc.
Exhibit 155: Pfizer Inc. - Overview
Exhibit 156: Pfizer Inc. - Product / Service
Exhibit 157: Pfizer Inc. - Key news
Exhibit 158: Pfizer Inc. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 164: Viatris Inc. - Overview
Exhibit 165: Viatris Inc. - Business segments
Exhibit 166: Viatris Inc. - Key news
Exhibit 167: Viatris Inc. - Key offerings
Exhibit 168: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations